OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Psychopharmacology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness	115
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping	58
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review	51
History repeating: guidelines to address common problems in psychedelic science	40
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study	31
A rapid clinical response to etifoxine in treatment-resistant obsessive-compulsive disorder: a case report of a patient with comorbid bipolar disorder	30
Comment on: History repeating: guidelines to address common problems in psychedelic science	29
Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysis	26
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study	26
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study	26
Adult psychiatrists’ views on clozapine prescribing for schizophrenia in Germany—an online survey	23
Psychotropic medications versus non-pharmacologic approaches for managing behavioural and psychological symptoms in Australian aged care residents with dementia: general practitioners’ and physicians’	23
Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”	21
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search system	19
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review	18
Sympathetic activation but not dissociation linked to ketamine’s sustained antidepressant effect	18
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia	17
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?	15
A description of antipsychotic prescribing patterns on the inpatient behavioral health setting: a multicenter cross-sectional analysis	15
Corrigendum to “Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis”	14
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review	12
Sex, drugs, and arousal—two randomized trials on the effects of ketamine on sexual arousal and calcarine gyrus activity	12
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychoti	12
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications	12
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand	11

Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine	11
The interplay between serotonin syndrome and syndrome of inappropriate antidiuresis: a fatal case of acute hyponatremia during treatment with duloxetine, chlorphenamine, amitriptyline, and L-tryptopha	10
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia	10
Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’	10
Healthcare resource savings from administering paliperidone palmitate once every 3 months instead of once every month for schizophrenia: a 12-month mirror-image analysis of real-world population-based	10
Impact of CYP1A , CYP2C19 , CYP2D6 ,	10
Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic review	9
Adjunctive aripiprazole for amisulpride-induced hyperprolactinemia: a preliminary retrospective study showing no reversing effect	9
Assessment of clozapine taste in healthy volunteers: evidence for non-aversive sensory profile	9
Psychedelic therapy and postpartum depression: priorities and prospects	9
Patient views on paliperidone palmitate 3-monthly: a cross-sectional questionnaire in UK community mental health teams	9
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies	8
The role of empathy in antidepressant withdrawal	7
Anticholinergic action is rarely a good thing	7
Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders	7
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review	7